The prevalence of pre-operative anaemia may be high among surgical patients, depending on the patients’ co-morbidities, gender, age and the underlying pathology for which they require surgery. In this regard, a recent systematic review showed that the weighted mean prevalence of anaemia was 24% in patients undergoing elective knee or hip surgery and 45% in those undergoing surgery because of a hip fracture1. In addition, it is worth noting that the proportion of older patients who undergo major orthopaedic surgery is rising progressively, and a high prevalence of anaemia (43%) was observed in a retrospective cohort of 57,636 veterans aged 65 years or older who underwent major elective and non-elective orthopaedic surgery2. Iron deficiency and chronic inflammation (including mild to moderate renal failure), with or without iron deficiency, are the most common causes of pre-operative anaemia, although deficiencies of iron, folic acid and/or vitamin B12 without anaemia are also frequent, especially among an elderly population. Saleh et al.3 reported that 19.6% (210/1,142) of admissions for elective total knee or hip replacement were anaemic compared with local population reference ranges (males 13 g/dL; females, 11.5 g/dL), with 76 of these anaemic patients having a haemoglobin (Hb) <11 g/dL and 13 having a Hb <10 g/dL. Regarding the types of anaemia, 135 had normocytic normochromic anaemia, 49 showed hypochromic varieties of anaemia, and 26 were classified as having other types of anaemia. Similarly, in another series of 715 patients undergoing major elective orthopaedic surgery the prevalence of pre-operative anaemia was 10.5%, because of haematinic deficiency (31%), chronic inflammation with or without iron deficiency (31%), and mixed or unknown cause (38%)4. Interestingly, iron deficiency was present in 18% of non-anaemic patients, vitamin B12 deficiency in 5%, and folate deficiency in 2%4. These deficiencies might blunt the response to erythropoiesis-stimulating agents, and delay the recovery from post-operative anaemia. In addition, almost 20% of patients had a Hb level <13 g/dL4 and it is well known that a low pre-operative Hb level is one of the major predictive factors for requiring peri-operative blood transfusion in orthopaedic surgery with moderate to high peri-operative blood loss5–7. In this regard, a European study including almost 4,000 patients showed an inverse relationship between pre-operative Hb values and the probability of receiving allogeneic blood transfusion (e.g., 10–18% for Hb 15 g/dL, 20–30% for Hb 13 g/dL, 50–60% for Hb 10 g/dL; 70–75% for Hb 8 g/dL)8. Similarly, 30 to 70% of patients undergoing hip fracture repair received allogeneic blood transfusion peri-operatively, and the logistic regression analysis identified pre-operative Hb value as an independent predictor of the need for these transfusions9. The limited physiological reserve and the higher prevalence of unrecognised cardiovascular disease may render the elderly population vulnerable to milder degrees of anaemia when undergoing the stress of surgery. In this regard, two large retrospective cohort studies of patients who underwent major non-cardiac surgery found that the adjusted risk of 30-day post-operative mortality and cardiac morbidity begins to rise when pre-operative haematocrit levels decrease to less than 39%2,10. On the other hand, major orthopaedic procedures are associated with a significant peri-operative blood loss. As a consequence, up to 90% of patients undergoing such procedures develop post-operative anaemia, which may be aggravated by inflammation-induced blunted erythropoiesis, especially through decreased iron availability (i.e, hepcidin-dependent down-regulation of intestinal absorption and impaired mobilisation from body stores)11. The correction of severe post-operative anaemia often requires allogeneic blood transfusion. Orthopaedic surgical patients at risk of developing severe post-operative anaemia and receiving peri-operative allogeneic blood transfusion should, therefore, be identified, on the basis of red blood cell mass (reflected by haemoglobin concentration on the day of pre-operative assessment), the lowest haemoglobin concentration that the patient can tolerate (transfusion trigger), and the expected blood loss (e.g., using Mercuriali’s algorithm)12. Whenever clinically feasible, these patients should have their Hb level and iron status (serum iron, ferritin, and transferrin saturation index) tested preferably 30 days before the scheduled surgical procedure13. For patients older than 60 years, vitamin B12 and folic acid should also be measured13. Any deficiency should be corrected prior to surgery, and unexplained anaemia should always be considered as secondary to some other process and, therefore, elective surgery should be deferred until a diagnosis has been made13,14.
Read full abstract